Dr. Jeffrey Irving Menashe, MD
- Medicare services, 2022
- 23,380
- Part D claims, 2022
- 756
- Clinical trials
- 1
- Hospital affiliations
- 1
- Industry payments
- $94,902
- Practice address
- 10150 Se 32nd Avenue, Milwaukie, OR 97222
- Practice phone
- Call (503) 513-8300
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Menashe's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jeffrey Irving Menashe is a hematologist and oncologist in Portland, Oregon
Dr. Menashe practices at Providence Milwaukie Hospital in Milwaukie, Oregon, part of Providence Health & Services.
Dr. Menashe's NPI, 1871596551, was assigned on May 24, 2005. Dr. Menashe graduated from Oregon Health Sciences University School of Medicine in 1981. Dr. Menashe holds Oregon license MD15990.
- NPI
- 1871596551NPI Registry (opens in a new tab)
- NPI enumeration date
- May 24, 2005
- NPI status
- Active
- Practice phone
- (503) 513-8300
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 71
- Medical school graduation
- 1981
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Jeffrey Irving Menashe practices at Providence Milwaukie Hospital in Milwaukie, Oregon
Dr. Menashe's primary practice is Providence Milwaukie Hospital, at 10150 Se 32nd Avenue, Milwaukie, OR 97222 in Clackamas County. The practice phone is (503) 513-8300.
- Providence Milwaukie Hospital10150 Se 32nd Avenue, Milwaukie, OR 97222 · Clackamas CountyPhone(503) 513-8300
Source: Dmand AI Affiliation Data
Dr. Jeffrey Irving Menashe is affiliated with 1 site of care
Dr. Menashe's primary practice is Providence Milwaukie Hospital in Milwaukie, Oregon, part of Providence Health & Services.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Jeffrey Irving Menashe's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Menashe practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Providence Milwaukie Hospital | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Providence Health & Services and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jeffrey Irving Menashe is one of 118 hematologists and oncologists in Oregon
Hematology and oncology is Dr. Menashe's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Menashe is licensed in Oregon.
Specialties and state licenses
- Hematology and oncology, OregonPrimary
Hematologists and oncologists near Dr. Menashe
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jeffrey Irving Menashe billed Medicare for 23,380 services in 2022
CMS data shows 23,380 Medicare services from Dr. Menashe across 28 procedure codes in 2022. Medicare paid $150,786 for them. Every service was in an office.
Dr. Menashe's Medicare services by type, 2021 to 2022
- 2021
- 2022
- Drugs given in the office
- 2021: 22,7032022: 13,26142%
- Other services
- 2021: 2472022: 6,6672599%
- Lab and pathology
- 2021: 3,1592022: 2,08434%
- Surgery
- 2021: 6942022: 50328%
- Office and hospital visits
- 2021: 6992022: 47632%
- Tests and treatments
- 2021: 6092022: 38936%
Dr. Menashe compared with the Oregon median for hematologists and oncologists, 2022
- Dr. Menashe
- Oregon median
- Medicare services
- 23,380vs 1,33117.6 times
- Part D claims
- 756vs 726Close to median
Medians across 122 hematologists and oncologists in Oregon with Dmand AI profiles that report each measure.
Dr. Menashe's most billed Medicare procedure codes, 2022
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Menashe?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Menashe and other hematologists and oncologists in Oregon.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Jeffrey Irving Menashe's patients have a median age of 77
Across all payers, Dmand AI patient panel data puts Dr. Menashe's median patient age at 77, with 47% women.
Dr. Menashe's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 77
Patient panel by sex, all payers
- Women47%
- Men53%
Source: Dmand AI Patient Panel Data
Dr. Jeffrey Irving Menashe wrote 756 Medicare Part D claims in 2022
In 2022, Dr. Menashe wrote 756 Medicare Part D claims. They cover 25 drugs, with $3,364,021 in total drug cost. In 2021, CMS named 1,139 claims across 38 drugs.
Dr. Menashe's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2021 to 2022
- 2021
- 2022
- Claims for drugs CMS names
- 2021: 1,1392022: 75634%
Drugs named by CMS: 25 in 2022, 38 in 2021.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Jeffrey Irving Menashe has worked on 1 clinical trial
Dmand AI links Dr. Menashe to 1 clinical trial. Conditions studied include Leukemia, Myeloid, Chronic-Phase and Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Conditions in Dr. Menashe's trials
- Leukemia, Myeloid, Chronic-Phase
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Investigators on the most trials with Dr. Menashe
- Guillermo Abesada-Terk, MD1 shared trial
- Luke Paul Akard, MD1 shared trial
- David Jacob Andorsky, MD1 shared trial
Recent clinical trials with Dr. Menashe
Sources: ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jeffrey Irving Menashe received $94,902 in industry payments from 2016 to 2023
CMS Open Payments shows 130 general payments to Dr. Menashe from 11 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 43% of the total. Celgene Corporation paid the most, $31,627.
General payments to Dr. Menashe by program year, 2016 to 2023
General payments to Dr. Menashe by kind, 2016 to 2023
- Speaker and faculty fees$40,96543%
- Consulting fees$38,71341%
- Travel and lodging$10,04411%
- Honoraria$2,8253%
- Other$2,3562%
Companies that paid Dr. Menashe the most, 2016 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Jeffrey Irving Menashe graduated from Oregon Health Sciences University School of Medicine
Dr. Menashe graduated from Oregon Health Sciences University School of Medicine in 1981.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Jeffrey Irving Menashe's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jeffrey Irving Menashe
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jeffrey Irving Menashe's NPI number?
Dr. Jeffrey Irving Menashe's NPI number is 1871596551. It was assigned on May 24, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Jeffrey Irving Menashe?
Dr. Jeffrey Irving Menashe is a hematologist and oncologist in Portland, Oregon. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Jeffrey Irving Menashe practice?
Dr. Menashe practices at 10150 Se 32nd Avenue, Milwaukie, OR 97222. Dr. Menashe's primary practice is Providence Milwaukie Hospital in Milwaukie, Oregon, part of Providence Health & Services.
What is Dr. Jeffrey Irving Menashe's office phone number?
The practice phone on file for Dr. Menashe is (503) 513-8300.
What is Dr. Jeffrey Irving Menashe's medical license number?
Dr. Menashe holds Oregon license MD15990.
Which hospitals is Dr. Jeffrey Irving Menashe affiliated with?
Dr. Menashe practices at Providence Milwaukie Hospital in Milwaukie, Oregon.
Does Dr. Jeffrey Irving Menashe accept Medicare?
Yes. CMS data shows Dr. Menashe billed Medicare for 23,380 services in 2022.
What services does Dr. Jeffrey Irving Menashe bill to Medicare?
In 2022, Dr. Menashe's most billed Medicare services were injected or infused drug (J0881), medicare temporary code (Q0138) and injected or infused drug (J1568).
Where did Dr. Jeffrey Irving Menashe go to medical school?
Dr. Menashe graduated from Oregon Health Sciences University School of Medicine in 1981.
What drugs does Dr. Jeffrey Irving Menashe prescribe most?
In 2022 Medicare Part D data, Dr. Menashe's most prescribed drugs by claims were Oxycodone HCl, Revlimid and Hydroxyurea.
Show 3 more questionsShow fewer questions
Has Dr. Jeffrey Irving Menashe received payments from drug or device companies?
CMS Open Payments shows $94,902 in general payments to Dr. Menashe from 11 companies from 2016 to 2023. The largest total came from Celgene Corporation.
How long has Dr. Jeffrey Irving Menashe been practicing?
Dr. Menashe graduated from medical school in 1981, 45 years ago.
Does Dr. Jeffrey Irving Menashe do research?
Dr. Menashe has worked on 1 clinical trial.
Selling to hematology and oncology practices?
See hematologists and oncologists in Oregon by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card